Merck KGaA has agreed to acquire Bio-Techne (NasdaqGS:TECH) for $11.5b in an all cash deal. Bio-Techne's board has ...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...
17h
Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)
Q1 beat and Bio-Techne deal drive upside, but valuation looks full. Read here for a detailed investment analysis.
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a ...
Bio-Techne Corp. will pay at least $215 million for a Texas company known for its screening technology for the fragile X carrier test and another kit that monitors leukemia patients for minimal ...
Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Bio-Techne Corporation (NASDAQ: TECH) to Merck ...
(TECH) was up 20.9% in pre-market trading, and Micron Technology Inc. (MU) was up 17.7%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results